icon star paper   Articles  
Back grey_arrow_rt.gif
  At a community meeting hosted by Roche 2 days ago, Roche announced they are freezing their HIV drug wholesale prices. This is in line with announcements by several other key HIV drug makers: GlaxoSmithKline, Abbott, Pfizer/Agouron, Bristol Myers Squibb. The Fair Pricing Coalition is a community group approaching additional HIV drug makers to follow suit. ADAP is a State and Federal program that provides HIV medications to individuals without private and public insurance. Although additional funding was requested this year to meet increased, funding for ADAPs has been in essence flat funded by Congress and the Administration. As a result, ADAP programs are initiating cutbacks. These price freezes are intended to help address this problem but will not solve the problem. In order to help you can contact your Congressional and Senatorial representatives and ask them to support additional funding for ADAP. ADAPs are also under pressure from the need to supply hepatitis C drugs for HIV-infected patients also infected with HCV and for the new upcoming HIV entry inhibitor drug T-20, which is expected to be FDA approved around March 2003.  
  icon paper stack View Older Articles   Back to Top   www.natap.org